Hua Shi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hua Shi has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Shuxiong Xu
Department of Urology, Guizhou Provincial People’s Hospital, Guiyang, China
3 shared publications - Yikun Wu
Department of Urology, Guizhou Provincial People’s Hospital, Guiyang, China
3 shared publications - Jieyu Xiong
Department for BioMedical Research, University of Bern, Bern, Switzerland
2 shared publications - Xiaoyu Wu
Faculty of Medicine of Duisburg-Essen University, Essen, Germany
2 shared publications - Yuangao Xu
Department of Urology, Guizhou Provincial People’s Hospital, Guiyang, China
2 shared publications - CiCi Guo
Department of Urology, Guizhou Provincial People’s Hospital, Guiyang, China
1 shared publication
Latest Publications
- Open Access
- 3 June 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-19
Identification of novel susceptibility loci for testicular germ cell tumors through multi-omics analysis
Objective This study aimed to identify potential susceptibility loci for testicular germ cell tumors (TGCT) through a comprehensive multi-omics analysis. Methods A Mendelian randomization (MR) analysis was conducted to investigate the causal relationships between immune cell phenotypes and TGCT. Summary-based Mendelian Randomization (SMR) and colocalization analyses were subsequently performed to examine candidate phenotypes and TGCT using quantitative trait locis from multiple datasets. Differential gene expression analysis was employed to explore the immune landscape of the target gene in the TGCT tumor microenvironment using UCSC databases. Additionally, potential pathway mechanisms were investigated to elucidate the functional role of candidate genes. Results MR analysis identified a significant causal association between the immune cell phenotype HLA-DR on monocytes and TGCT (p = 0.02). SMR analysis revealed that BDH2 was significantly associated with TGCT susceptibility (OR = 0.597, p = 2.21e-07). Colocalization analysis suggested shared genetic variation between BDH2 and TGCT (PP.H4 = 0.95). Immunohistochemistry staining confirmed that BDH2 mRNA levels were significantly lower in TGCT tissues than in normal controls (p < 0.001). In the TGCT tumor microenvironment, lower BDH2 expression was associated with higher immune scores, with T cells and B cells predominantly enriched in the low-expression group, whereas monocytes and endothelial cells were more abundant in the high-expression group. Furthermore, members of the HLA family, exhibited significant correlations between their methylation levels and low BDH2 expression groups. Pathway analysis indicated that BDH2 may influence TGCT progression through the RAS-MAPK signaling pathway. Conclusions Our findings support a significant susceptibility relationship between the phenotype HLA-DR on monocytes, BDH2, and TGCT.
- 3 June 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-19
Open AccessIdentification of novel susceptibility loci for testicular germ cell tumors through multi-omics analysis
Objective This study aimed to identify potential susceptibility loci for testicular germ cell tumors (TGCT) through a comprehensive multi-omics analysis. Methods A Mendelian randomization (MR) analysis was conducted to investigate the causal relationships between immune cell phenotypes and TGCT. Summary-based Mendelian Randomization (SMR) and colocalization analyses were subsequently performed to examine candidate phenotypes and TGCT using quantitative trait locis from multiple datasets. Differential gene expression analysis was employed to explore the immune landscape of the target gene in the TGCT tumor microenvironment using UCSC databases. Additionally, potential pathway mechanisms were investigated to elucidate the functional role of candidate genes. Results MR analysis identified a significant causal association between the immune cell phenotype HLA-DR on monocytes and TGCT (p = 0.02). SMR analysis revealed that BDH2 was significantly associated with TGCT susceptibility (OR = 0.597, p = 2.21e-07). Colocalization analysis suggested shared genetic variation between BDH2 and TGCT (PP.H4 = 0.95). Immunohistochemistry staining confirmed that BDH2 mRNA levels were significantly lower in TGCT tissues than in normal controls (p < 0.001). In the TGCT tumor microenvironment, lower BDH2 expression was associated with higher immune scores, with T cells and B cells predominantly enriched in the low-expression group, whereas monocytes and endothelial cells were more abundant in the high-expression group. Furthermore, members of the HLA family, exhibited significant correlations between their methylation levels and low BDH2 expression groups. Pathway analysis indicated that BDH2 may influence TGCT progression through the RAS-MAPK signaling pathway. Conclusions Our findings support a significant susceptibility relationship between the phenotype HLA-DR on monocytes, BDH2, and TGCT.
- 6 May 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (9) , 11810-11821
Uncovering Potential Susceptibility Genes for Multiple Sclerosis-Induced Neuropathic Bladder: A Mendelian Randomization Analysis
Despite lacking a genetic explanation for the causal link between multiple sclerosis (MS) and neuropathic bladder (NPB), our study aims to explore this causality and identify novel susceptibility genes for both phenotypes. We performed linkage disequilibrium score regression to assess SNP heritability for both phenotypes. Two-sample bidirectional Mendelian randomization (MR) analyses were conducted to evaluate causal relationships between MS and NPB. We performed pathway enrichment analysis on instrumental SNPs and applied summary-data-based MR (SMR) with protein and expression quantitative trait loci. Candidate susceptibility genes were further examined through colocalization analysis and differential expression studies. Our analyses indicate a substantial genetic contribution to both MS and NPB phenotypes. MR analysis revealed that MS progression increased NPB risk (OR = 1.126; 95% CI. 1.052–1.205; p < 0.001), with no evidence of reverse causality. Pathway analysis highlighted NIK/NF-kappaB signaling and autophagosome maturation as potentially shared mechanisms. SMR (p_FDR < 0.05) and colocalization analyses (PP.H4 > 0.75) identified NFKB1 and STAT3 as candidate susceptibility genes. Transcriptomic analyses confirmed significant differential expression of these genes (p < 0.05) between MS patients and healthy controls. Our findings established a causal relationship between MS progression and NPB risk, with NFKB1 and STAT3 emerging as promising therapeutic targets for MS-induced NPB.
- 6 May 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (9) , 11810-11821
Uncovering Potential Susceptibility Genes for Multiple Sclerosis-Induced Neuropathic Bladder: A Mendelian Randomization Analysis
Despite lacking a genetic explanation for the causal link between multiple sclerosis (MS) and neuropathic bladder (NPB), our study aims to explore this causality and identify novel susceptibility genes for both phenotypes. We performed linkage disequilibrium score regression to assess SNP heritability for both phenotypes. Two-sample bidirectional Mendelian randomization (MR) analyses were conducted to evaluate causal relationships between MS and NPB. We performed pathway enrichment analysis on instrumental SNPs and applied summary-data-based MR (SMR) with protein and expression quantitative trait loci. Candidate susceptibility genes were further examined through colocalization analysis and differential expression studies. Our analyses indicate a substantial genetic contribution to both MS and NPB phenotypes. MR analysis revealed that MS progression increased NPB risk (OR = 1.126; 95% CI. 1.052–1.205; p < 0.001), with no evidence of reverse causality. Pathway analysis highlighted NIK/NF-kappaB signaling and autophagosome maturation as potentially shared mechanisms. SMR (p_FDR < 0.05) and colocalization analyses (PP.H4 > 0.75) identified NFKB1 and STAT3 as candidate susceptibility genes. Transcriptomic analyses confirmed significant differential expression of these genes (p < 0.05) between MS patients and healthy controls. Our findings established a causal relationship between MS progression and NPB risk, with NFKB1 and STAT3 emerging as promising therapeutic targets for MS-induced NPB.
- Open Access
- 27 May 2024
- Published by Springer Nature in Discover Oncology
- Vol. 15 (1) , 1-14
miR-4429 inhibits ccRCC proliferation, migration, and invasion by directly targeting CD274
Clear cell renal cell carcinoma (ccRCC) is one of the most aggressive urological malignancies and a highly immunogenic cancer. Yet, its pathogenesis is still not fully understood. This study analyzed the role of the miR-320 family in ccRCC using bioinformatics algorithms and a series of in vitro experiments. miR-4429 was found to be significantly down-regulated in ccRCC tissues and cell lines, while overexpression of miR-4429 significantly inhibited renal cancer cell proliferation, migration, and invasion in vitro. In addition, the UALCAN database, immunohistochemistry, and protein blotting results showed that CD274 expression was up-regulated in ccRCC tissues and correlated with higher histologic grading. Dual luciferase assay indicated that CD274 was a direct target of miR-4429. Overexpression of miR-4429 in 786-O, Caki-2 cells significantly inhibited CD274 expression. KEGG results indicated that the potential target function of miR-4429 was associated with the PI3K/AKT signaling pathway, and protein blotting verified the results. In summary, this data shows that miR-4429 targets CD274 and inhibits ccRCC proliferation, migration, and invasion by regulating PI3K/AKT signaling, thus potentially providing a promising therapeutic target and prognostic biomarker for renal cell carcinoma patients. Graphical Abstract
- 27 May 2024
- Published by Springer Nature in Discover Oncology
- Vol. 15 (1) , 1-14
Open AccessmiR-4429 inhibits ccRCC proliferation, migration, and invasion by directly targeting CD274
Clear cell renal cell carcinoma (ccRCC) is one of the most aggressive urological malignancies and a highly immunogenic cancer. Yet, its pathogenesis is still not fully understood. This study analyzed the role of the miR-320 family in ccRCC using bioinformatics algorithms and a series of in vitro experiments. miR-4429 was found to be significantly down-regulated in ccRCC tissues and cell lines, while overexpression of miR-4429 significantly inhibited renal cancer cell proliferation, migration, and invasion in vitro. In addition, the UALCAN database, immunohistochemistry, and protein blotting results showed that CD274 expression was up-regulated in ccRCC tissues and correlated with higher histologic grading. Dual luciferase assay indicated that CD274 was a direct target of miR-4429. Overexpression of miR-4429 in 786-O, Caki-2 cells significantly inhibited CD274 expression. KEGG results indicated that the potential target function of miR-4429 was associated with the PI3K/AKT signaling pathway, and protein blotting verified the results. In summary, this data shows that miR-4429 targets CD274 and inhibits ccRCC proliferation, migration, and invasion by regulating PI3K/AKT signaling, thus potentially providing a promising therapeutic target and prognostic biomarker for renal cell carcinoma patients. Graphical Abstract